# Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

> **NCT04759885** · PHASE2,PHASE3 · COMPLETED · sponsor: **NTC srl** · enrollment: 886 (actual)

## Conditions studied

- Elective Colonoscopy

## Interventions

- **DRUG:** Phase II: NTC015 low dose
- **DRUG:** Phase II: NTC015 medium dose
- **DRUG:** Phase II: NTC015 high dose
- **DRUG:** Phase III: NTC015 selected dose
- **DRUG:** Phase III: Polyethylene glycol plus ascorbate solution (2L PEG ASC)

## Key facts

- **NCT ID:** NCT04759885
- **Lead sponsor:** NTC srl
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-18
- **Primary completion:** 2021-07-16
- **Final completion:** 2021-07-16
- **Target enrollment:** 886 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04759885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04759885, "Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04759885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*